Skip to main contentSkip to navigation
Sirius Investors

DHR Stock: Danaher Corporation Stock Price, Analysis & Insights

Get live dhr stock price $226.98, comprehensive Danaher Corporation stock analysis, charts, news, and expert forecast. Real-time dhr stock data and investment insights.

226.98
0.18%Today
DHRDanaher Corporation • New York Stock Exchange • Healthcare
Market Cap
162.64B
Volume
4.08M
52W High
258.23
52W Low
171.00

Loading chart...

Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Company Information

CEO
Rainer M. Blair
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
61000

Contact Information

Address
2200 Pennsylvania Avenue, NW
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Market leader with 162.6 billion market capitalization

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 46.6)

Business Model & Strategy

Danaher Corporation operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a mid-cap company, Danaher Corporation benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Rainer M. Blair, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

Danaher Corporation competes in the Medical - Diagnostics & Research within the broader Healthcare. With 162.6 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Danaher Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Danaher Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Danaher Corporation shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Danaher Corporation
  • Investors should consider how Danaher Corporation fits within their overall portfolio allocation
  • Premium valuation (P/E: 46.6) requires strong growth to justify

Market Cap

162.64B

P/E Ratio

46.61

Beta

0.93

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 162.64B market capitalization
  • Trading Volume: 4.08M shares traded today
  • Price Range: 52-week range of $171.00 - $258.23
  • Exchange: Listed on New York Stock Exchange

Financial Metrics

P/E Ratio:46.61
EPS:$4.87
Beta:0.93
Avg Volume:4.15M

Market Analysis for Danaher Corporation

Danaher Corporation (DHR) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 162.64B, the company represents a significant player in its market. The stock is currently trading at $226.98 with a negativedaily change of 0.18%.

The company's 61000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 46.61, beta of 0.93, and 52-week price range from $171.00 to $258.23when evaluating investment opportunities.

Why Invest in Danaher Corporation?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (New York Stock Exchange)
  • • Experienced leadership under Rainer M. Blair
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.